Fortitude Family Office’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184 | Sell |
89
-192
| -68% | -$397 | ﹤0.01% | 1968 |
|
|
2025
Q1 | $618 | Hold |
281
| – | – | ﹤0.01% | 1070 |
|
|
2024
Q4 | $430 | Hold |
281
| – | – | ﹤0.01% | 1226 |
|
|
2024
Q3 | $559 | Hold |
281
| – | – | ﹤0.01% | 1155 |
|
|
2024
Q2 | $984 | Hold |
281
| – | – | ﹤0.01% | 883 |
|
|
2024
Q1 | $778 | Hold |
281
| – | – | ﹤0.01% | 913 |
|
|
2023
Q4 | $478 | Buy |
+281
| New | +$478 | ﹤0.01% | 976 |
|